Metabolic Health
Digital health solutions to help you achieve your metabolic targets, through nutrition, lifestyle, pharmaceutical and digital interventions.
Our Metabolic Health Services
Digital Diet Assessment
A quick, personalised way to assess and improve your nutrition
The Digital Diet Assessment (DDA) is a one-hour virtual dietitian consultation to assess your diet intake and provide a personalized meal plan.
Recommended for:
- Individuals with chronic conditions such as type 2 diabetes, hypertension, dyslipidemia and fatty liver.
- Older adults who require dietary support.
- Anyone with specific nutritional concerns.
Watch how Digital Diet Assessment works
Digital Diet Assessment in three simple steps
FIT-10 is a 2-month weight loss program led by a registered dietitian, with focus on gradual, sustainable changes with continuous support and progress tracking.
Recommended for:
- Individuals who are overweight or obese.
- Anyone seeking sustainable, evidence-based weight management.
The FIT-10 journey includes:
Diabetes
Treat-To-Target
6-month intensive care to improve diabetes health targets
Diabetes Treat-To-Target (T2T) is a 6-month intensive program guided by your diabetes nurse, and dietitian to improve your blood sugar, blood pressure, and weight. Aimed to help you achieve clinical remission.
Recommended for:
- Individuals newly diagnosed with type 2 diabetes.
- Individuals with suboptimal type 2 diabetes control.
- Individuals with type 2 diabetes motivated to reduce reliance on medications through lifestyle intervention.
The Diabetes T2T journey includes:
Future-Fit is a 4-month Digital Weight Loss Program supported by a GP, dietitian and pharmacist, paired with a GLP-1 receptor agonist medication.
Recommended for:
- Individuals who are overweight or obese. (BMI ≥ 25)
- Individuals who struggle with weight loss despite consistent diet and exercise.
- Individuals who are struggling with prediabetes.
- Individuals who are overweight and have high blood pressure or high cholesterol.
- Individuals with obesity and at high risk of cardiovascular events.
*Individuals with a BMI < 25, history of Medullary Thyroid Carcinoma (MTC) or MEN-2, plans for pregnancy within 2 months, or known semaglutide allergies are ineligible. All participants undergo clinical screening by a GP to ensure safety.
